Trials / Completed
CompletedNCT04864899
Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- The University of Hong Kong · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This is a prospective cohort study that aims to clinical significance of subclinical myocardial involvement in recovered COVID-19 patients using cardiovascular magnetic resonance.
Detailed description
This study aims to: 1. Determine the extent of myocardial involvement of COVID-19, as assessed by Cardiovascular Magnetic Resonance (CMR), 2 weeks after patient recovery, at 3-month post discharge and at 1-year post discharge. 2. Correlate these myocardial characteristics to biventricular structure, function, blood biomarkers of inflammation, clinical symptoms, and functional capacity at all time points. 3. Follow up recovered COVID-19 patients beyond the end of this study to assess for hard outcomes such as death, heart failure hospitalization, cardiac arrest and ventricular tachycardia/ fibrillation. Recovered COVID-19 patients and age and gender matched controls subjects will be recruited.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Cardiac Magnetic Resonance Imaging (CMR) | Imaging |
| DIAGNOSTIC_TEST | Blood test | Blood investigation |
| DIAGNOSTIC_TEST | 6-minute walk test | Correlating the cardiac MRI parameters with functional capacity |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2024-08-06
- Completion
- 2024-08-06
- First posted
- 2021-04-29
- Last updated
- 2025-05-11
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT04864899. Inclusion in this directory is not an endorsement.